1-5 of 5
Authors: Nicolas A. Margot
Journal Article
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years Get access
The Journal of Infectious Diseases, jiaf050, https://doi.org/10.1093/infdis/jiaf050
Published: 28 January 2025
Journal Article
Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants
The Journal of Infectious Diseases, Volume 229, Issue 5, 15 May 2024, Pages 1290–1294, https://doi.org/10.1093/infdis/jiad562
Published: 07 December 2023
Journal Article
Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir
The Journal of Infectious Diseases, Volume 226, Issue 11, 1 December 2022, Pages 1985–1991, https://doi.org/10.1093/infdis/jiac364
Published: 09 September 2022
Journal Article
Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
The Journal of Infectious Diseases, Volume 215, Issue 6, 15 March 2017, Pages 920–927, https://doi.org/10.1093/infdis/jix015
Published: 30 January 2017
Journal Article
Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine Get access
The Journal of Infectious Diseases, Volume 207, Issue suppl_2, June 2013, Pages S70–S77, https://doi.org/10.1093/infdis/jit114
Published: 15 June 2013
